Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Trial Of Tarceva In Patients With Recurrent/Progressive Glioblastoma Multiforme

NCT00054496 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00054496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00054496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Trial Of Tarceva In Patients With Recurrent/Progressive Glioblastoma Multiforme
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2002
Completion date
Not reported
Enrollment
73 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors